Letter by Gronda et al Regarding Article, "Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial"

被引：3
|
作者：
Gronda, Edoardo [1 ]
Colivicchi, Furio [2 ]
Zuccala, Giuseppe [3 ]
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UOC Nefrol Dialisi & Trapianto Renale Adulto, Milan, Italy
[2] Azienda Complesso Osped San Filippo Neri, Rome, Italy
[3] Fdn Policlin Univ Agostino Gemelli IRCSS, Cardiol Clin & Riabilitat, Rome, Italy
来源：
CIRCULATION | 2022年 / 145卷 / 16期
关键词：
D O I：
10.1161/CIRCULATIONAHA.121.057530
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E839 / E840
页数：2
相关论文
共 50 条
  • [31] Empagliflozin in Heart Failure with a Preserved Ejection Fraction
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao P.
    Bocchi, Edimar
    Boehm, Michael
    Brunner-La Rocca, Hans-Peter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure-Valenzuela, Eduardo
    Giannetti, Nadia
    Gomez-Mesa, Juan Esteban
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Carson, Peter
    Lam, Carolyn Su Ping
    Marx, Nikolaus
    Zeller, Cordula
    Sattar, Naveed
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16): : 1451 - 1461
  • [32] Design and rationale of the EMPagliflozin outcomE tRial in patients with chrOnic heaRt failure (EMPEROR-Preserved)
    Butler, J.
    Packer, M.
    Filippatos, G.
    Zannad, F.
    Salsali, A.
    Kimura, K.
    Schnee, J.
    Zeller, C.
    Pocock, S.
    George, J.
    Brueckmann, M.
    Anker, S. D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 232 - 232
  • [33] Drug treatment with empagliflozin was beneficial in people with heart failure with preserved ejection fraction: plain language summary of the EMPEROR-Preserved study
    Zannad, Faiez
    Macari, Steven
    [J]. FUTURE CARDIOLOGY, 2023, 19 (14) : 671 - 677
  • [34] Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
    Pocock, Stuart J.
    Ferreira, Joao Pedro
    Packer, Milton
    Zannad, Faiez
    Filippatos, Gerasimos
    Kondo, Toru
    McMurray, John J., V
    Solomon, Scott D.
    Januzzi, James L.
    Iwata, Tomoko
    Salsali, Afshin
    Butler, Javed
    Anker, Stefan D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1869 - 1878
  • [35] Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis
    Ferreira, Joao Pedro
    Zannad, Faiez
    Packer, Milton
    Filippatos, Gerasimos
    Pocock, Stuart J.
    Vasques-Novoa, Francisco
    Boehm, Michael
    Butler, Javed
    Anker, Stefan
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (04) : 952 - 959
  • [36] Letter by Wang Regarding Article, "Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial"
    Wang, Junwen
    [J]. CIRCULATION, 2024, 150 (06) : e106 - e106
  • [37] Empagliflozin benefits in patients with heart failure and preserved ejection fraction
    Anker, Stefan D.
    Butler, Javed
    Usman, Muhammad Shariq
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Bocchi, Edimar
    Boehm, Michael
    Brunner-La Rocca, Hans Pieter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure, Eduardo
    Giannetti, Nadia
    Esteban Gomez-Mesa, Juan
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Iwata, Tomoko
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    [J]. NATURE MEDICINE, 2022, 28 (12) : 2480 - 2481
  • [38] Empagliflozin benefits in patients with heart failure and preserved ejection fraction
    [J]. Nature Medicine, 2022, 28 : 2480 - 2481
  • [39] Response to Letter Regarding Article, "The Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction"
    Pal, Nikhil
    Sivaswamy, Nadiya
    Mahmod, Masliza
    Yavari, Arash
    Rudd, Amelia
    Singh, Satnam
    Dawson, Dana K.
    Francis, Jane M.
    Dwight, Jeremy S.
    Watkins, Hugh
    Neubauer, Stefan
    Frenneaux, Michael
    Ashrafian, Houman
    [J]. CIRCULATION, 2016, 133 (16) : E604 - E604
  • [40] Empagliflozin in the treatment of heart failure with preserved ejection fraction
    Morbach, C.
    Frantz, S.
    Nitschmann, S.
    [J]. INNERE MEDIZIN, 2022, 63 (07): : 808 - 809
12345